Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.98% | 10.21% | 9.16% | 7.06% | 13.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.98% | 10.21% | 9.16% | 7.06% | 13.18% |
| Cost of Revenue | 10.19% | 10.90% | 9.42% | 7.87% | 11.54% |
| Gross Profit | 9.57% | 8.90% | 8.63% | 5.41% | 16.54% |
| SG&A Expenses | 5.03% | 9.58% | 7.56% | 6.35% | 15.05% |
| Depreciation & Amortization | -5.13% | -2.56% | -5.13% | 0.00% | 21.88% |
| Other Operating Expenses | -200.00% | -- | -- | -100.00% | 200.00% |
| Total Operating Expenses | 8.78% | 10.50% | 8.71% | 7.34% | 12.51% |
| Operating Income | 16.91% | 8.67% | 11.99% | 5.38% | 17.28% |
| Income Before Tax | 26.49% | 7.38% | 14.97% | 10.86% | 11.26% |
| Income Tax Expenses | 28.57% | -9.28% | 25.42% | 19.12% | 18.46% |
| Earnings from Continuing Operations | 25.87% | 12.84% | 12.34% | 8.47% | 9.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 0.00% | 20.00% | 21.43% | -27.27% |
| Net Income | 27.35% | 13.48% | 14.55% | 10.36% | 8.41% |
| EBIT | 16.91% | 8.67% | 11.99% | 5.38% | 17.28% |
| EBITDA | 13.49% | 7.02% | 10.06% | 5.92% | 16.32% |
| EPS Basic | 29.89% | 14.55% | 15.65% | 11.36% | 8.00% |
| Normalized Basic EPS | 22.08% | 13.85% | 14.71% | 13.10% | 14.10% |
| EPS Diluted | 28.70% | 14.98% | 15.46% | 10.97% | 8.54% |
| Normalized Diluted EPS | 20.97% | 13.83% | 14.69% | 14.11% | 14.09% |
| Average Basic Shares Outstanding | -1.79% | -0.89% | -0.90% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.88% | -0.88% | -0.88% | -0.88% | 0.00% |
| Dividend Per Share | 7.50% | 7.50% | 7.50% | 6.67% | 6.67% |
| Payout Ratio | -0.16% | -0.06% | -0.09% | -0.03% | -0.02% |